HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Cleveland BioLabs, Inc. (CBLI)
2.24  -0.33  (-12.84%) 07-02 02:44
Open: 2.45 High: 2.56
Pre.close: 2.57 Low: 2.1585
Volume: 1,063,222 Ave vol: 1,254,241
52w High: 5 52w Low: 0.5
MA(50): 1.925 MA(200): 1.821
EPS: -0.209 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.cbiolabs.com
Market Cap (M): 29
Shares Out (M): 13
Cleveland BioLabs Inc is a biopharmaceutical company developing novel approaches to activate immune system & address medical needs. Its proprietary platform of toll-like immune receptor activators are used in radiation, oncology immunotherapy & vaccine.
Technical analysis
Overall: Underperform
MA: Bullish MACD: Bullish
KDJ: Bearish RSI: Bearish
Target 1: 3.84 Target 2: 5.17
Resist 1: 3.28 Resist 2: 4.43
Support 1: 1.43 Support 2: 1.19
Company key metrics
Revenue per Share: 0.0816
Net Income per Share: -0.2757
Cash per Share: 0.0997
Book Value per Share: -0.4004
Price to Sales: 38.5918
Price to Book Value: -7.8675
Earnings Yield: -0.0875
Dividend Yield: 0
Debt to Equity: -1.4503
Debt to Assets: 3.2209
Financial analysis
Price to Book Value: Underperform
Return on Assets: Underperform
Return on Equity: Outperform
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Underperform
Stock Charts
Headline news
Fri, 26 Jun 2020
Understanding the Risk vs Reward for Cleveland BioLabs, Inc. (CBLI) - The News Heater

Fri, 26 Jun 2020
Is Cleveland BioLabs, Inc. (CBLI) Stock a Good Buy? - InvestorsObserver

Wed, 01 Jul 2020
Are Investors Keen On Selling Holdings In Cleveland BioLabs, Inc. (NASDAQ:CBLI)? - Stocks Register

Mon, 29 Jun 2020
Why should you add Cleveland BioLabs, Inc. (CBLI) to your portfolio? - Marketing Sentinel

Tue, 09 Jun 2020
How is Cleveland BioLabs, Inc. (CBLI) Stock's Recent Performance Affecting Investor's Feelings? - InvestorsObserver

Wed, 03 Jun 2020
Cleveland BioLabs Closes $3.175 Million Registered Direct Offering Priced At-The-Market Under NASDAQ Rules - Yahoo Finance

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.